Bimeda has announced the launch of Butagran Equi (phenylbutazone), to join its range of analgesics and anti-inflammatories.
Bimeda says that Butagran Equi provides rapid onset of activity with the added convenience for horse owners or professionals of being presented as an easy-to-administer sweetened powder.
Indications include musculo-skeletal conditions that require relief from pain and a reduction in the associated inflammation, including lameness associated with osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation.
Head of Bimeda technical services Padraig Hyland MVB said: "Butagran Equi is particularly suited where continued mobility is considered desirable. It is also of value in limiting post-surgical inflammation, myositis and other soft tissue inflammation and can be used as an anti-pyretic where this is considered advisable, such as in viral respiratory infections. And being a sweetened powder it's quite straightforward for horse owners to administer and dose as prescribed."
He added: "Butagran Equi follows the launch of a number of new products and is proof our desire to provide a comprehensive and relevant equine portfolio backed up with first class technical support."
NOAH Chair Gaynor Hillier said: "The production and supply of veterinary medicines is totally dependent on complex international supply chains that must continue to function effectively after Brexit, their unique status being recognised in the recent government White Paper.
"Raw materials will need to arrive at manufacturing sites and veterinary medicines will need to be transported across borders to meet market requirements. Any border delays, additional complex processes or increased costs will risk medicines availability for UK vets, farmers and all our animals."
According to a recent NOAH member survey, less than 15% of companies say they are prepared for a 'hard Brexit' with the vast majority of respondents saying they are not fully prepared should there be a reversion to WTO rules on 30 March 2019.
NOAH says this is not through lack of effort or unawareness of the need to act, but due to the magnitude of the complex tasks involved in such a specialist sector, coupled with uncertainty over what a 'no-deal' Brexit will look like.
In contrast, almost 60% of companies said they are prepared for a transition period to December 2020. Even then, NOAH says the proposed transition period will not be enough in some cases.
The survey examined product availability in the UK: almost 55% of respondents reported potential availability issues for the UK market impacting more than 40% of their products. The full spectrum of types of products (from vaccines to painkillers: from antibiotics to wormers) across all animal species (farm, equine and pet) are potentially at risk, with particular concerns raised around the supply chain for vaccines.
The one day course for general practitioners will be presented by Dr Sonya Miles, an RCVS Recognised Advanced Practitioner in Zoological Medicine and lead clinician for Highcroft Exotic Vets (an RWAF Gold accredited practice).
It's worth 7.5hrs of CPD. Sonya will be covering:
This course costs £250 and includes lunch, tea/coffee/biscuits, and a certificate of completion.
Apparently there are acres of parking. For those not able to attend, www.justexotics.co.uk has an extensive library of free content including: fact sheets, care sheets, protocols and “How to” videos covering exotic mammals, reptiles, birds, amphibians, fish, invertebrates and British wildlife, as well as a constantly expanding catalogue of webinars covering these species.
Virbac is running a promotion through which practices can claim a model showing the anatomy of a healthy dog ear canal on one side, and the changes associated with chronic damage on the other.
Product Manager Chris Geddes MRCVS said: "The models are about 15cm high and provide a useful visual aid to show clients the consequences if chronic ear disease is not kept under control. They can also be used to help show clients how to administer their pet's treatment correctly.
"These models will be a useful tool for practices to help improve client compliance. Also, we know that some dog owners find a course of ear treatments tricky, and either give the wrong dose or give up altogether, which is why we designed EasOtic to dispense the exact dose in one simple 'squirt', with one complete course in each bottle".
For details of how you can obtain a model for your practice contact your local Virbac territory manager or call Virbac on 01359 243243.
Following last year's campaign, Merial commissioned a survey to learn more about how horse owners seek and receive information about the wider aspects of preventative healthcare, and in particular about the relationship with their veterinary practice.
In the survey of 455 horse owners, which was carried out by CMI Research, 78% said their veterinary surgeon was the most important source of information. The next most important influencers were yard managers/grooms at just 22%.
Louise Radford MRCVS from Merial said: "We wanted to learn more about client education and the opportunities for practices to get more from their client relationships, including vaccination and booster uptake. However we hadn’t estimated just how much horse owners rely on their vet for information!"
"However there appears to be a significant gap between vets as a source of information, and their client’s purchasing habits. Health plans are a great example of the potential for improved compliance, with benefits to the horse, client and practice. Yard health plans present an opportunity to increase booster uptake and also to include animals that might not otherwise be vaccinated.
"Of those horse owners and grooms surveyed who did not vaccinate some or all of their horses, their reasons included horses that never leave the yard, or are old, young, or do not interact with other horses. Yet we know that horses that don’t travel are still at risk of equine flu, as virus can travel up to a mile as an aerosol on the wind, in addition to being carried on objects such as buckets and tack.
"So as the key influencers on preventative healthcare, there is much that practices can do to further engage with clients to increase uptake of products and services, improve client loyalty, and ultimately boost the practice business."
For more information on Equine Flu Awareness Month- 2017, including client materials and video content, visit www.equinefluawareness.com
At the outset of the hearing, which was to consider evidence for a number of charges relating to the treatment of three colts at his former practice in 2015, Mr Denny made an application to the Committee that the hearing should be adjourned contingent on a form of undertakings being accepted. These undertakings were that his name be removed from the Register with immediate effect and that he never apply to be restored to the Register under any category.
The application was granted by the Committee, taking into account a number of factors. These include the fact that Mr Denny had now retired and closed his practice, his long and hitherto unblemished veterinary career and the fact that it would not be proportionate, or in the public interest, for there to be a lengthy hearing on the matter.
The Committee noted that there were several precedents for concluding cases in such a manner. The Committee also noted that the application was supported by both the College and the complainant.
Mr Denny was removed from the Register as of Monday 24 April 2017.
The company says the webinars will equip veterinary professionals with strategies to strengthen wellbeing both individually and for practice teams.
Lauren Hayes, Scientific and Regulatory Affairs Manager at Royal Canin, said: “Working within clinical veterinary practice can be hugely rewarding and enriching, but it cannot be ignored that our industry also has its challenges.
"Veterinary surgeons have a significantly higher risk of suicide compared to the general population and mental health issues around work life balance and compassion fatigue are widespread.
"Through our webinar series, we hope to encourage conversations around mental health and help provide advice directly from leading experts.”
The one-hour webinars will take place at 7pm every Wednesday throughout September.
https://vetportal.royalcanin.co.uk/news/new-veterinary-professional-health-webinar-series/
Merck and sanofi-aventis, owners of Merial and Intervet Schering-Plough respectively, have announced that they will not be combining the two animal health businesses as had been planned since March 2010.
In a joint announcement today, the companies said they are discontinuing their agreement primarily because of the increasing complexity of implementing the proposed transaction, both in terms of the nature and extent of the anticipated divestitures and the length of time necessary for the worldwide regulatory review process. The companies agreed that ending their plan is in the best interests of both companies and their respective shareholders, as well as the employees of Merial and Intervet/Schering Plough.
Sanofi-aventis says it remains strongly committed to its animal health activities, which it will continue to develop under the Merial brand as a growth platform of its diversified health business. Merial is one of the world's leading innovation-driven animal healthcare companies dedicated to research, development, manufacturing and commercialization of veterinary pharmaceuticals and vaccines, that generated annual sales of US $ 2.6 billion in 2010.
Merck has also stated its commitment to animal health and Intervet/Schering-Plough, a global leader in the research, development, manufacturing and sale of veterinary medicines which generated sales of US $ 2.9 billion in 2010
As a result of termination, both Merial and Intervet/Schering-Plough will continue to operate independently.
Dr Crespo appeared in front of the Disciplinary Committee earlier this week with two charges against her. The first was that, in November 2015, she dishonestly and falsely made an online representation to the College that she had no criminal convictions, cautions or adverse findings despite having been convicted, in January 2015, of failing to provide a specimen of breath. The second charge against her was that, in March 2016, she once again dishonestly and falsely failed to declare her conviction when renewing her registration.
During the hearing the Committee had two main considerations in respect of both charges – as to whether Dr Marin Crespo had been dishonest in failing to declare the conviction and as to whether the respondent ought to have known that her representations were false. Regarding the dishonesty element, the Committee found the College had not sufficiently proven this, as it accepted Dr Marin Crespo’s evidence that she did not believe she needed to declare a motoring-related offence as it was not relevant to her professional practice.
However, the Committee found it proven that the respondent ought to have known that the representations were false, taking into account that Dr Marin Crespo made admissions that she ought to have checked the guidance on declaring convictions, cautions and/or adverse findings and ought to have been aware that making such declarations is a requirement of the RCVS Code of Professional Conduct.
Having found the parts of the two charges relating to false representation proven, the Committee then considered whether this constituted serious professional misconduct.
Judith Webb, chairing the Committee and speaking on its behalf, said:"The Committee considers that the false declarations made by the respondent were born of a careless disregard for the disclosure process. The Committee notes that the respondent could easily have checked online, and/or by telephone, as to what she was obliged to do when making the relevant declarations. She failed to do that.
"In these circumstances, the Committee considers that the respondent’s conduct fell far short of that which is to be expected of the veterinary profession. Therefore, in the judgement of the Committee, on the facts found proved, the respondent is guilty of disgraceful conduct in a professional respect."
In considering Dr Marin Crespo’s sanction the Committee took into account a number of mitigating factors including her full cooperation with the College’s investigation, her hitherto unblemished career, her testimonial evidence which it felt demonstrated her dedication and professionalism, and the fact that she has displayed remorse and insight into her conduct.
Judith Webb concluded: "The Committee notes that the respondent’s conduct caused no harm, or risk of harm, to animals or humans. The Committee also notes that there is no charge arising out of the criminal conviction itself. The Committee considers that, if the respondent had answered the online questions correctly, it is unlikely that the respondent would have appeared before the Committee.
"Every veterinary surgeon must ensure that they adopt a careful and accurate approach to the self-certification exercise, which is crucial if the public and the College are to have trust in that process. In these circumstances, the Committee considered that the proportionate sanction in this case is that the respondent be… reprimanded for her conduct."
The awards celebrate outstanding veterinary surgeons and nurses, practices, practice managers and support staff who’ve been nominated by their clients and colleagues for their hard work, dedication and going that extra mile to keep the nation’s pets healthy.
This year, there were over 37,000 nominations. The finalists are:
Practice Support Staff of the Year
Practice Manager of the Year
Practice of the Year
Vet Nurse of the Year
Vet of the Year
James Barnes, head of sales and partnerships at Petplan, said: “We’re delighted to announce the finalists for the annual Veterinary Awards, which honours the exceptional work carried out by some of the best veterinary professionals in the country. Congratulations to all the 2020 finalists on this fantastic achievement.
“We understand that that this remains an extremely challenging time, which is why we would like to bring the veterinary profession together so we can say thank you for your ongoing dedication to the care of pets. This is particularly true when we consider the devoted teams and individuals continuing to care for the nations pet during the COVID-19 outbreak. Whilst we might not be celebrating together in person this year we hope as many people as possible will join us online for this exciting celebratory event.”
The awards will be hosted on Facebook @PetplanUK on Thursday 28th May 8.30pm. For more information: https://www.petplanvet.co.uk/veterinary-practice-insurance/veterinary-awards.
Kit, or, to give him his full title, Dr Kit Sturgess MA, VetMB, PhD, CertVR, DSAM, CertVC, FRCVS, RCVS Recognised Specialist in Small Animal Medicine, has been working as an internist in private referral practice since 2003. In 2006 he became a founding partner in a multidisciplinary referral centre that he saw grow from five to 65 members of staff within five years.
He is also Chair of BSAVA Education Committee, Trustee of Cats Protection and Chair of Trustees of the Wildheart Trust. He was formerly an RCVS Knowledge Trustee and member of RCVS Council.
Kit has authored numerous articles and two textbooks, and presents lectures and research abstracts at conferences worldwide.
Kit will take up the editorship on 2nd September, succeeding Professor Peter Cockcroft. He said: “I am delighted to take on the editorship of Veterinary Evidence. With readers in 150 countries and output that has more than doubled over the past three years, the journal has quickly become a mainstay of evidence-based veterinary medicine, which is a testament to Peter’s enthusiasm and commitment to the development of the journal and its impact on the veterinary community.
"I am excited about leading Veterinary Evidence in its next stage of development, with recent events showing the critical importance of open online access. Veterinary Evidence is ideally placed to support an ever-growing and wide range of veterinary professionals by further developing a multimedia, multiplatform approach facilitating the use of evidence-based medicine in their daily practice."
Veterinary Evidence journal can be read at: veterinaryevidence.org
MSD says that no other UK-licensed BRD vaccine can be administered earlier in life and that the onset of immunity for BRSV is 6 days (for calves vaccinated from the day of birth onwards) and 5 days (for calves vaccinated from the age of one week onwards).
Onset of immunity for Pi3V is one week after vaccination. The duration of immunity is 12 weeks for both viruses.
From a practical standpoint, the new license means Bovilis Intranasal RSP Live can now be used on farm at the same time as other early life interventions associated with newborn calves – for example, colostrum/first milk feeding, navel management, tagging, jacketing and necessary pen movements.
Additionally, Bovilis Intranasal RSP Live can be used up to six hours after mixing with the solvent, which MSD says is the longest of all the available intranasal vaccines for these pathogens.
The vaccine is supplied as a nasal suspension product that doesn’t need a specific applicator – although for maximum flexibility an easy-clean injector and nozzle kit is available for vaccinating multiple animals.
The vaccine is available in 5x1 dose, 5 dose and 5x5 dose packs.
The project, which has been supported by Zoetis, came about after 45 vets from 35 CVS practices identified osteoarthritis (OA) as the main clinical area their practice team wanted to develop over the next 18 months.
As a result, the VOA and CVS came together and signed a Memorandum of Understanding under which the VOA will support CVS with training, resources and research.
The goal is to improve the care of OA patients by engaging the whole practice team and clients in their pets’ care.
Professor Stuart Carmichael, VOA Director said: “VOA’s aim is to provide access to the latest research, evidence and technologies and facilitate a multi-professional collaboration supporting practices wishing to improve their management of osteoarthritis.
CVS practices participating in this project will become eligible for accreditation by the VOA in recognition of the training they've undergone.
As the project develops, CVS says it will assess the results of the initiative, learning more about strategies that can improve and enhance management of OA.
This should translate into the development of better long-term approaches for the management of OA that can be used across the profession.
Meantime, the Veterinary Osteoarthritis Alliance (VOA) has a practice accreditation scheme which is available to any practice which is looking to improve its management of OA.
Further information is available at: vet-oa.com
The ISFM says Congress will offer veterinary professionals an extensive scientific programme designed to support a multi-modal and cat friendly approach to caring for feline patients with acute upper urinary tract disease and other emergencies.
Speakers will include Søren Boysen (Emergency & Critical Care), Serge Chalhoub (Internal Medicine), Laura Owen (Soft Tissue Surgery) and special guest Allyson Berent (Non-Invasive Surgery).
Sam Taylor MRCVS, ISFM Veterinary Specialist Lead (pictured right) said: "We seem to be seeing more and more feline urinary cases, urolithiasis and acute kidney injury - and of course the familiar blocked cats!
"In Dublin, I can’t wait to hear how to approach these cases as well as look more in-depth at ECC and discuss cat friendly critical care amongst many other topics from all angles – surgery, medicine, behaviour, imaging and more!’
The 2023 ISFM Feline Congress Dublin is open to veterinary surgeons and nurses of all experience levels.
https://icatcare.org/congress-2023-dublin/
The survey of 50 vets carried out in May this year1 found that only half of them are recommending strangles vaccination to their clients.
They also felt that horse owners could be doing more to combat the disease.
Less than half of vets questioned believed that yards and premises operated good biosecurity measures prior to a strangles outbreak, yet 85% brought in more stringent biosecurity after an outbreak, when it was too late.
Dechra says that vets and horse owners can help combat the estimated 300 outbreaks of strangles each year with the following steps:
Sara Barker BVSc CertAVP(EM) MRCVS, equine field support manager at Dechra, said: “Strangles is one of the most common equine infectious diseases both in the UK and worldwide and a multi-factor approach is key to tackling the disease.
"Strangles vaccination is recommended, alongside good biosecurity, quarantine measures and regular temperature checking.
"By working together, vets and horse owners can help to keep horses healthy and prevent the spread of strangles.”
Reference
Membership of the Dechra Academy is free and gives access to content from key opinion leaders examining topics such as diagnosis and treatment, monitoring and best practice.
The Academy covers subjects like anaesthesia, analgesia, endocrinology, dermatology and fluid therapy relating to exotics, equines, companion animals and food-producing animals.
The Academy includes webinars, eLearning, eBooks and videos, all of which provide CPD credits with downloadable certificates.
Dechra is currently running a new series of webinars through the Academy about how to successfully manage cases with the constraints of the coronavirus outbreak as part of its enhanced support for veterinary professionals.
Roddy Webster, Country Manager for the UK and ROI, said: "The Dechra Academy offers a vast range of valuable training support materials developed and led by our technical veterinary advisors and industry key opinion leaders. The platform reinforces our commitment to supporting the veterinary profession in the development of veterinary skills and knowledge.
“The refreshed Academy is more intuitive and flexible to use with improved functionality and navigation that makes it easier to access training as and when it suits the user.
“A community of more than 30,000 veterinary professionals are already benefiting from the learning opportunities available through the Academy and we would encourage anyone looking for exceptional and free CPD support to sign up now.”
To register for free access to the Dechra Academy, visit: www.dechra.co.uk/academy.
330 people who took part in the survey were presented with a list of management and leadership skills. Those of the respondents who are leaders were asked to rate their confidence in applying the skills, whilst those in non-management positions were asked to rate their line manager's skills. Both sets of respondents were also asked to place the skills in priority order.
The management skills were: Setting clear tasks and objectives. Providing clear roles and responsibilities. Communicating clearly and effectively. Monitoring and evaluating. Planning and organising. Effectively managing difficult situations.
The leadership skills were: Providing rationale and explaining why. Regularly providing and seeking feedback. Building trust. Providing guidance and training. Creating development plans and opportunities.
Interestingly, the survey found a close correlation between how the leaders and the employees prioritise these things, with management skills being perceived as more important overall than leadership skills.
Communicating clearly and effectively was deemed the most important skill of all (ranked 9 out of 10 by both groups). Meanwhile, creating development plans and opportunities for others was prioritised the least (ranked 3.7/10).
But hang on a moment. If both the managers and the employees agree that creating development plans and opportunities is the least important thing, then surely it is? In other words, if employees say that creating development plans is unimportant, then surely it is unimportant, and if leaders think the same, they would appear to be right.
Maybe, maybe not. Perhaps employees don't know what's good for them, and leaders don't know what employees don't know what is good for them. If you take my point.
Veterinary leaders were then asked to rate their confidence in applying the listed leadership and management skills. The skills which elicited the largest number of 'not confident' responses were: monitoring and evaluating performance, regularly providing and seeking feedback, and creating development plans and opportunities for others.
The skills with which leaders were most confident were: communicating clearly and effectively, building trust, and providing rationale and explaining why.
Again, there was a close correlation between prioritisation of these skills and confidence levels.
VMG Vice President Richard Casey said: “The survey has helped us to identify priorities for learning and development both at our 2020 Congress and during our joint CPD programme next year. It is striking that the very skills required to motivate colleagues to remain in veterinary medicine and to support them in doing so are the ones which so many veterinary leaders admit that they lack confidence. Given the challenges the profession faces, it is also concerning that they appear to be undervalued both by veterinary leaders and the team members who report to them.
"Delegates to SPVS-VMG Congress and our other 2020 CPD events will benefit from a wealth of evidence-based lectures from experts on all aspects of veterinary leadership and management, enabling them to improve their own performance and contribute to an overall raising of standards of leadership and management across the veterinary sector."
Peter Brown, Senior Vice-President of SPVS, said: "We know that veterinary students receive an excellent clinical training and, in recent years, universities have started to include more non-clinical skills on the curriculum. However, these results suggest that when professionals move into more senior roles, be it leading a team or running their own practice, they find they still need to acquire new skills. SPVS’ role has always been to equip veterinary professionals to be effective leaders and SPVS-VMG congress is an excellent opportunity to both hear inspiring speakers and meet and learn from fellow leaders within the profession."
The VMG-SPVS 2020 joint Congress takes place from 23-25 January at the Celtic Manor Resort, Newport, and will feature dedicated streams on effective leadership, management mastery, practice profitability, preparing for a digital future and sustainability in practice.
Details on the VMG-SPVS 2020 CPD Programme can be found here: https://spvs-vmg-events.co.uk/cpd-events/
An environmental photojournalist, Mr Gekoski has won various well-known wildlife photography awards and is regularly featured in the press, most recently for his book Animosity: Human - Animal Conflict in the 21st Century.
Aaron will join BVA President James Russell, Association of Veterinary Students (AVS) Senior Vice President Izzie Arthur and two other judges nominated by the competition sponsor iM3 Veterinary Dentistry. The BVA photography competition has already had over 200 entries for this year's award since it launched in January. Split into three categories, entrants are asked to focus on images that capture the human-animal bond in day-to-day veterinary work, as well as photos of pets or wildlife taken outside of the working environment.
Submissions for each category can be taken on a phone or a high-spec camera, and should take into account responsible animal interaction and positive animal health and welfare.
The three categories are:
Aaron said: “It's a huge honour to be a judge for the BVA Veterinary Photographer of the Year Award, the most prestigious photographic competition for the veterinary profession. The competition helps shine a light on the invaluable and relentless work carried out by vets around the world; work that may otherwise go unnoticed. I look forward to bringing my experience as an environmental photojournalist to the judging process."
The BVA Veterinary Photographer of the Year Award 2021 closes at 11.59 GMT on 8th March 2021. Winners will be announced in April. They will receive a £250 John Lewis voucher and their pictures exhibited by BVA.
Find out more and submit your entries at www.bva.co.uk/photo-comp
Protek Biochem Ltd., a company set up by champion horse-rider Debbie Topping, has won the rights to sell Envirocair Veterinary, a new range of disinfectants and sanitisers targeted at dogs, cats and other domestic pets, as well as horses and farm animals.
The product is claimed to kill 99.99% of all viral, bacterial and fungal infections, and lasts for 14 days.
Debbie said: "I did not consider myself a businesswoman, just a normal horse-rider and animal lover. However, I was so impressed when I tried Envirocair Veterinary that, when I was offered the opportunity to become the main UK distributor, I jumped at the chance."
According to the company, the product is being used by a number of the horses and trainers heading to the London Olympics in 2012. It is now being rolled out across the rest of the UK's animal care sector.
Debbie says that veterinary surgeons, farmers, dog kennels, animal rescue centres, breeders and others will all be able to benefit from the new product: "Envirocair Veterinary doesn't harm skin or irritate the respiratory tract, so you don't need to get dressed up in special clothing every time you use it.
"Used properly, it quite literally kills the threat of major animal diseases such as parvovirus in dogs, which can otherwise be fatal in less than 72 hours.
"It's not an exaggeration to say that Envirocair will protect the health and even save the lives of countless numbers of animals across the UK."
Debbie signed the distribution agreement with the manufacturer Biotech International Ltd last month, before officially launching Envirocair Veterinary this week.
For more information on Protek Biochem Ltd or Envirocair Veterinary, visit http://www.protekbiochem.com/.
Sureflap, the microchip pet door company has teamed up with animal behaviourist Jon Bowen MRCVS to provide a free CPD-qualifying presentation about improving cats' quality of life with simple modifications to their environment.
In the 45-minute webinar Jon explains how the domestic environment impacts on the cat's territory and the stress this creates. He also offers practical advice on how owners can make the space feel safer for the pet.
To view the webinar go to www.sureflap.co.uk/vet/cpd/territory-stress. Complete the quiz at the end, and you'll be sent a CPD certificate.
Royal Canin has announced the launch of its Christmas promotion through which practice clients will be rewarded with activity balls for cats and leashpods for dogs.
The stocking fillers will be distributed to practices along with promotional materials such as posters and shelf wobblers, to encourage clients to buy Royal Canin Veterinary Care Nutrition (VCN) pet food.
Veterinary Marketing Manager, Lindsay Calcraft, said: "Customers who purchase any 1.5kg bag of feline VCN or any 3.5kg bag of canine VCN from their vet will receive a cat activity ball or a leashpod to thank them for their custom and support.
"For those who don't know what a leashpod is, it's a fantastic dog lead handle to help you carry all those essential items needed for walking a dog. It has an integrated bag dispenser, its own scented mini bin for storing smelly used bags and two secure pockets for treats, keys, money or your mobile phone."
For more information about the Christmas promotion, visit www.royalcanin.co.uk or contact your Veterinary Business Manager.
Davies Veterinary Specialists, the small animal referral hospital based at Higham Gobion in Hertfordshire, has reported treating four cases of serious lungworm (Angiostrongylus vasorum) infection over the past couple of months, all within around 30 miles of each other.
The practice says it usually sees only two or three lungworm cases a year, at most. It is thought that the increase in cases could be the result of a lack of knowledge amongst some owners about the right wormers to use, as well as the fact that lungworm appears to be getting a stronger foothold in some areas, possibly due to factors such as climate change.
One of the cases referred to DVS was a Cocker Spaniel called Honey belonging to Irené O'Hanlon-Marin from Beaconsfield. Vets initially believed the dog's symptoms of neck pain, breathlessness, shaking and lethargy to be the result of a recent head injury. Serious alarm was raised when Honey appeared to suffer a fit three weeks later, became unable to walk and lost her vision in one eye. She was immediately referred to DVS as an emergency.
Peter Smith, Neurology Specialist at DVS, said: "Honey was in a pretty serious condition when admitted here and would, I suspect, have died if she'd been left another few hours. She's now back home and much improved, and appears to be regaining her sight."
Irené O'Hanlon-Marin said: "It scares me to think how little I knew about lungworm and the fact that I need to use a specific wormer for it. We have been so lucky with Honey but I am determined to help prevent other dogs going through what she suffered so we all need to help spread the word about the dangers of this parasite."
The other three cases referred to DVS were from High Wycombe, Pinner and St Albans. The practice reports that all patients have recovered well.
The self-adhesive dressing, which uses a patented natural polymer, adapts to any part of the body and sets fast, acting as a waterproof barrier to the external environment which shields the site from unwanted moisture and bacterial ingress and allows the tissue underneath to repair in a protected environment.
It is proven to prevent the loss of therapeutic sprays when it is used as a barrier1.
The company says NoBACZ Bovine is easy to apply with a clean gloved hand and offers up to seven days’ protection without the need to reapply.
It is suitable for use on any site of the body, except the eyes, and has been especially widely used on hooves, horn buds and udders.
The liquid barrier dressing does not need to be removed as it will self-degrade and its ingredients dissolve naturally with no residue.
Dr Jonathan Powell, Director of Biomineral Research and Imaging at the University of Cambridge’s Department of Veterinary Medicine, and chief executive officer and co-founder of NoBACZ Healthcare, said: “Following several years of research at the University of Cambridge and comprehensive market analysis which identified an unmet need across the farming industry, we are absolutely delighted to launch NoBACZ Bovine, which offers unparalleled protection against harsh farm conditions, revolutionising wound protection in cattle and enhancing the health and welfare of the national herd.”
Mike Kerby, veterinary surgeon from Synergy Farm Health, who has used NoBACZ Bovine over many months, added: “I have been using NoBACZ Bovine for a while in cattle affected with UCD (udder cleft dermatitis) and DD (digital dermatitis) lesions as well as on wounds and granulomas.
"It is my clinical impression that it counters bacterial colonisation rapidly and promotes re-epithelialisation, which in turn helps to prevent the occurrence of proud flesh or reduces the mass of any existing granulomata.
"Application is simple and quick, with clients also finding it easy to reapply regularly within set treatment protocols.
"In addition to this, it was seen as a huge advantage that bandages and their removal are not involved, nor are antibiotics, making it labour saving, sustainable and eco-friendly.”
www.nobacz.com
Elanco Companion Animal Health has announced that its Duvaxyn IE and IE-T Plus vaccines have been licensed for active immunisation against OIE recommended clade 1 and clade 2 equine influenza strains, the first vaccines to be so licensed.
The company says the updated license is a result of a recent challenge study which demonstrated the ability of Duvaxyn IE-T Plus equine influenza vaccine to induce cross protection against clade 2 strain A/equi-2/Richmond/1/07 (H3N8) two weeks after two doses of the primary course1 were given. Cross-protection was further supported by another study2 measuring serum antibody response to the Richmond '07 strain 52 weeks after the three dose primary vaccination course.
The OIE (World Organisation for Animal Health) updated its equine influenza vaccine recommendations in 2010 to reflect the fact that all field strains characterised through 2008 and 2009 were of clade 1 or 2 of the Florida sub-lineage. The antigenic difference between viruses of these clades could potentially compromise the effectiveness of vaccines containing a representative of a single clade3.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health UK, said: "Whilst no vaccine has been updated to match the current OIE recommendations, the results of our challenge study and subsequent licence update provide reassurance that horses vaccinated with Duvaxyn will be protected against clinical signs of disease caused by currently circulating strains of equine influenza, including those the OIE has identified as being of concern.
"Further reassurance is also given with the confirmation in our study that Duvaxyn IE-T Plus elicits a cell mediated immune response, recognised to play an important role to aid in viral clearance and further enhances protection against strains circulating in the field." 4
The live virus challenge study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two doses of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Richmond/1/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
Duvaxyn IE-T Plus is the only inactivated whole virus carbomer adjuvanted equine influenza vaccine in the UK. According to Elanco, experts in the field of human vaccination have expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins including the conserved nucleoprotein, which shows no antigenic drift, in the vaccine5.
References
The materials available include a scour management guide for farmers and a more detailed version for vets. They encourage a focus on three main areas for improved, sustained disease control: maximising calf immunity; identifying any causal agents and how to effectively manage an outbreak of calf scour on farm.
MSD Animal Health veterinary adviser Dr Kat Baxter-Smith (pictured right) said: "Even with good disease prevention protocols in place, calf scour outbreaks can still occur. But when they do, remedial action should focus on these three key areas to resolve the outbreak as quickly as possible and reduce the chances of another costly event happening in the future.
The company highlights a 202 survey of more than 300 farms, which found that over 80% of UK calf rearing units had seen a case of scour in the previous 12 months; with 50% of farms admitting to experiencing calf deaths due to the disease1. Costs are estimated at £57.94 per case but this does not include the longer-term impacts of the disease on future calf productivity.2,3